X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (8) 8
humans (8) 8
middle aged (6) 6
differentiation (5) 5
oncology (5) 5
cell biology (4) 4
heart failure (4) 4
hematology (4) 4
index medicus (4) 4
male (4) 4
mesenchymal stromal cells - metabolism (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
cancer (3) 3
case-control studies (3) 3
cell differentiation (3) 3
cell lineage (3) 3
cell proliferation (3) 3
cells, cultured (3) 3
cellular senescence (3) 3
chronic lymphocytic leukemia (3) 3
female (3) 3
gene expression regulation (3) 3
heart failure - metabolism (3) 3
heart failure - pathology (3) 3
proliferation (3) 3
repair (3) 3
senescence (3) 3
adult stem cells - metabolism (2) 2
adult stem cells - pathology (2) 2
aged (2) 2
aged, 80 and over (2) 2
biomarkers - metabolism (2) 2
bone marrow multipotent mesenchymal stromal cells (2) 2
care and treatment (2) 2
cell (2) 2
cell culture techniques (2) 2
cell hypoxia (2) 2
cell separation (2) 2
cell therapy (2) 2
double-blind (2) 2
expression (2) 2
fibrosis (2) 2
guidelines (2) 2
hypoxia (2) 2
medical prognosis (2) 2
medicine & public health (2) 2
mesenchymal stromal cells - pathology (2) 2
myocardial-infarction (2) 2
myofibroblas (2) 2
natriuretic peptides - metabolism (2) 2
natriuretic peptides system (2) 2
patients (2) 2
phenotype (2) 2
regeneration (2) 2
research paper (2) 2
signal transduction (2) 2
studies (2) 2
therapy (2) 2
treatment outcome (2) 2
vidarabine - administration & dosage (2) 2
vidarabine - analogs & derivatives (2) 2
activation (1) 1
acute disease (1) 1
acute lymphatic leukemia (1) 1
acute lymphoblastic-leukemia (1) 1
acute myelogenous leukemia (1) 1
acute myeloid-leukemia (1) 1
adiponectin (1) 1
adipose tissue-derived mesenchymal stem cells (1) 1
adolescent (1) 1
adoptive immunotherapy (1) 1
age factors (1) 1
alemtuzumab (1) 1
analysis (1) 1
anti-cd20 monoclonal antibody (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antigens, differentiation - metabolism (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
apoptosis (1) 1
apoptosis - radiation effects (1) 1
atrial-fibrillation (1) 1
b-cell (1) 1
b-cell lymphoma (1) 1
binding (1) 1
biology (1) 1
biomedicine (1) 1
bioscience (1) 1
blood and marrow transplantation (1) 1
blood diseases (1) 1
body mass index (1) 1
bone marrow cells - metabolism (1) 1
bone marrow cells - physiology (1) 1
bone marrow cells - secretion (1) 1
bone marrow stromal cells (1) 1
bone marrow transplantation - methods (1) 1
bone marrow-derived mesenchymal stem cells (1) 1
bone-marrow (1) 1
bone-marrow transplantation (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 10, pp. 9021 - 9029
T and NK cells armed with chimeric antigen receptors (CAR) are promising tools for the specific elimination of cancer cells. In most CAR designs implemented to... 
Chimeric antigen receptors | VEGFR2 | FnCAR | NK cells | Fn3
Journal Article
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 7/2006, Volume 55, Issue 7, pp. 830 - 840
T cell targeting immunotherapy is now considered in acute myelogenous leukemia (AML), and local recruitment of antileukemic T cells to the AML microcompartment... 
CXCL10 | Acute myelogenous leukemia | Biomedicine | Immunology | CCL5 | Oncology | Cancer Research | CCL17 | CELLS | ACTIVATION | acute myelogenous leukemia | FUNCTIONAL-CHARACTERIZATION | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | CHEMOTHERAPY | STRATEGIES | IN-VITRO CULTURE | ONCOLOGY | INFLAMMATION | OSTEOBLASTS | DIFFERENTIATION | Neoplastic Stem Cells - secretion | Burkitt Lymphoma - blood | Age Factors | Chemokines, CC - blood | Chemokines, CC - secretion | Fibroblasts - physiology | Osteoblasts - secretion | Chemokines, CXC - blood | Coculture Techniques | Humans | Middle Aged | Culture Media, Conditioned - chemistry | RNA, Messenger - analysis | Male | Leukemia-Lymphoma, Adult T-Cell - physiopathology | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Chemotaxis, Leukocyte - drug effects | Neoplasm Proteins - secretion | Aged, 80 and over | Adult | Female | Tumor Cells, Cultured - secretion | Burkitt Lymphoma - drug therapy | Chemokine CCL5 | Acute Disease | Chemokine CCL17 | Cell Communication | Burkitt Lymphoma - physiopathology | Infection - physiopathology | Chemokine CXCL10 | Chemokines, CXC - secretion | Leukemia, Myeloid - drug therapy | Leukemia-Lymphoma, Adult T-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Leukemia, Myeloid - physiopathology | Adolescent | Neoplasm Proteins - blood | T-Lymphocytes - immunology | Aged | Leukemia, Myeloid - blood | Stromal Cells - physiology | Infection - complications | Leukemia, Myeloid - complications
Journal Article
Annals of Hematology, ISSN 0939-5555, 11/2018, Volume 97, Issue 11, pp. 2153 - 2161
CLL is an aging-associated neoplasm with median age at diagnosis > 65 years. Little is known about safety and efficacy of FC/FCR regimens in elderly CLL... 
CLL | Chronic lymphocytic leukemia | Medicine & Public Health | Hematology | Comorbidities | FCR | Oncology | CIRS-G | SURVIVAL | CHEMOIMMUNOTHERAPY | CYCLOPHOSPHAMIDE | GUIDELINES | FLUDARABINE | TRIAL | MYELOID-LEUKEMIA | HEMATOLOGY | CELL | EXPRESSION | PROGRESSION | Medical colleges | Medical research | Comorbidity | Analysis | Medicine, Experimental | Medical records | Index Medicus
Journal Article
Journal Article
Reproductive Toxicology, ISSN 0890-6238, 09/2019, Volume 88, pp. 134 - 134
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3107 - 3107
Abstract BACKGROUND: Ruxolitinib is a potent JAK1/JAK2 inhibitor that has proved superior to placebo and best available therapy in the phase 3 COMFORT studies... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 3785 - 3785
Abstract Abstract 3785 Bosutinib (BOS) is an orally active, dual Src/Abl tyrosine kinase inhibitor (TKI). This open-label, phase 1/2 study evaluated BOS in... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.